Ganxun Li

机构：Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-2874-8753

发表论文 38 篇 · 总被引 832 次 · h-index 13

代表论文

• CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1 (2023 · International Journal of Biological Sciences · 被引 77)
• Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation (2022 · Cell Death and Differentiation · 被引 68)
• Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti–PD-1 resistance in hepatocellular carcinoma (2025 · Science Immunology · 被引 41)
• Clinical characteristics and risk factors for mortality in cancer patients with COVID-19 (2021 · Frontiers of Medicine · 被引 40)
• Serum amylase elevation is associated with adverse clinical outcomes in patients with coronavirus disease 2019 (2021 · Aging · 被引 12)
• Optimizing Management to Reduce the Mortality of COVID-19: Experience From a Designated Hospital for Severely and Critically Ill Patients in China (2021 · Frontiers in Medicine · 被引 10)